[Linezolid for the treatment of newborns infected with vancomycin-resistant Enterococcus faecium].
Griselda Berberián, G Castro, Silvia Fistolera, Mónica Travaglianti, Horacio Ángel Lopardo, Antonio Mastroianni, María Teresa Rosanova
Abstract
Griselda Berberián, G Castro, Silvia Fistolera, Mónica Travaglianti, Horacio Ángel Lopardo, Antonio Mastroianni, María Teresa Rosanova
Abstract
Five patients hospitalized in the neonatal unit between 2002 and 2007, infected with vancomycin-resistant Enterococcus faecium treated with linezolid are presented in this study. This antibiotic showed good clinical efficacy and safety, since no adverse events occured in this group of patients.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Five patients hospitalized in the neonatal unit between 2002 and 2007, infected with vancomycin-resistant Enterococcus faecium treated with linezolid are presented in this study. This antibiotic showed good clinical efficacy and safety, since no adverse events occured in this group of patients.
Key concepts: Linezolid, Enterococcus faecium, Enterococcus, Vancomycin, Medicine, Vancomycin-resistant Enterococcus, Adverse effect, Antibiotics